Tefron Ltd.
TFRFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $82 | $81 | $93 | $94 |
| - Cash | $4 | $8 | $7 | $6 |
| + Debt | $24 | $20 | $12 | $12 |
| Enterprise Value | $102 | $94 | $98 | $100 |
| Revenue | $55 | $69 | $59 | $63 |
| % Growth | -19.6% | 16.5% | -6.9% | – |
| Gross Profit | $10 | $15 | $13 | $13 |
| % Margin | 18.7% | 21.3% | 21.7% | 20.6% |
| EBITDA | $1 | $7 | $5 | $4 |
| % Margin | 2.5% | 9.5% | 8.8% | 6.3% |
| Net Income | -$2 | $3 | $2 | $2 |
| % Margin | -3.5% | 4.9% | 3.1% | 3% |
| EPS Diluted | -0.15 | 0.26 | 0.14 | 0.15 |
| % Growth | -157.7% | 85.7% | -6.7% | – |
| Operating Cash Flow | -$2 | $0 | $9 | $6 |
| Capital Expenditures | -$5 | -$4 | -$4 | -$2 |
| Free Cash Flow | -$7 | -$4 | $5 | $4 |